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mpending and pathologic fractures of long bones in patients with metastatic skeletal disease are generally treated with intramedullary nailing. The combination of neoplastic disease, loss of mechanical stability, vessel damage, and immobility would theoretically put these patients at substantial risk for the development of venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE).
There are many known risk factors for the development of VTE 1, 2 . Virchow's original description of this problem proposed that VTE occurs as the result of a triad of factors: alterations in blood flow, vascular endothelial injury, and a hypercoagulable state 3 . The relatively high VTE risk of orthopaedic procedures 4 is related to intraoperative and postoperative factors. Estimated rates of inpatient DVT and PE among patients receiving prophylaxis following hip or knee arthroplasty are approximately 0.5% to 1% 5 . The risk of VTE is also increased in long-bone fractures [6] [7] [8] [9] [10] [11] [12] . Aggressive anticoagulation postoperatively, however, must be balanced with the risk of severe wound or bleeding complications 13, 14 .
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The mechanisms for cancer-related hypercoagulability include cancer procoagulant, vascular compression or tumor invasion, prothrombotic chemotherapy, and radiation therapy 15, 16 . VTE was found to occur in up to 11% of patients with cancer 17, 18 , and cancer patients undergoing orthopaedic surgery are presumably at very high risk 19, 20 . Indeed, a recent study demonstrated a mildly increased risk of VTE in cancer patients undergoing routine joint arthroplasty when cancer was not present at the site of the operation (odds ratio [OR] = 1.2 to 1.6); the risk substantially increased when the arthroplasty was performed for an oncologic indication (OR = 6.6) 21 . The risk factors for VTE in patients with malignancy have been described in a number of large, population-based, case-control studies [22] [23] [24] [25] [26] [27] [28] , but the risk in patients undergoing intramedullary nailing for prophylactic fixation related to skeletal metastases is unknown.
The purpose of the current study was to determine the risk of thromboembolic events in patients with metastatic long-bone cancer undergoing intramedullary nailing for skeletal metastatic disease, to define the risk factors for developing VTE in this group, and to define the rate of wound complications in this population.
Materials and Methods

Data Collection
A fter institutional review board approval, a retrospective review of surgical databases at three National Cancer Institute (NCI)-designated cancer centers identified 287 patients with a total of 336 impending or pathologic long-bone fractures that were stabilized with intramedullary nailing between February 2001 and April 2013. In all cases, the treating orthopaedic oncologist determined the postoperative anticoagulation protocol. These three institutions were chosen because of the variation in postoperative anticoagulation regimens, while maintaining identical surgical technique. Postoperatively, patients were generally allowed to bear full weight on the operatively treated limb immediately after surgery.
Data and Statistical Analysis
Adjuvant therapies recorded included any postoperative radiation specifically to the affected limb and any postoperative chemotherapy. Specific details of chemotherapeutic agents used were not obtained in all cases. Rates of documented VTE, divided into PE and DVT, and any postoperative anticoagulation details were recorded. Routine lower-extremity screening ultrasounds were not obtained in any of the centers studied, so it is likely that all DVTs identified were symptomatic because all patients with DVT did have ultrasound documentation. With the exception of one patient with renal cell carcinoma, who was diagnosed with use of a ventilation/ perfusion (V/Q) scan, all patients with PE had documentation by a chest computed tomography (CT) scan. Wound complications, defined as requiring either reoperation or other modification of treatment (such as the initiation of antibiotic therapy), were recorded. Statistical analysis was performed by a statistician utilizing Fisher exact tests and multivariable logistic regression analysis. ORs and 95% confidence intervals (CIs) were calculated. A p value of <0.05 was considered significant.
Source of Funding
No external funding was received for this study.
Results
Patient Demographics
P atient demographics and clinical and disease-specific characteristics are shown in Table I . Of the 287 patients, the median age was 60.5 years (range, twenty-eight to ninety-four years). One hundred and fourteen (39.7%) of the patients were male, and 173 (60.3%) were female. Of the 336 operations, 264 1504 16, 2015 (78.6%) involved the femur; 62 (18.4%), the humerus; and 10 (3.0%), the tibia. Eighteen major cancer diagnostic categories were identified (Table I) .
Adjuvant Therapies
Any postoperative radiation therapy delivered to the affected limb commencing within a two-week time frame of surgery was recorded. Dosages ranged from 20 to 40 Gy. Details of the radiation field and non-VTE radiation-associated complications were not recorded. Because of the large variety of primary oncologic diseases and the corresponding large number of medical oncology physicians treating the patients in the study population, detailed records regarding the specifics of chemotherapy used could not be obtained in all cases. The distribution of adjuvant therapies is shown in Table I .
Anticoagulant Data
Low-molecular-weight heparin was the most frequently used anticoagulant and was documented for 203 (60. 16, 2015 operations, no form of chemical anticoagulant was given, and for two (0.6%), the anticoagulant could not be verified (Table II) .
VTE Data
There were twenty-four documented VTE events: thirteen PE (3.9% of the operations) and eleven DVT (3.3%) (Table III) . The number of VTE events according to time of occurrence.
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The twenty-four events occurred in nineteen (6.6%) of the patients (twenty-one [6.3%] of the nailing procedures). The patients (four [21. 1%] male and fifteen [78.9%] female) had a median age of fifty-nine years (range, forty-three to eighty-one years). Lung cancer was the most common oncologic diagnosis. In nine (42.9%) of the twenty-one cases, adjuvant radiation was received, and in six (28.6%), adjuvant chemotherapy. Lowmolecular-weight heparin was the most frequently used anticoagulant in the subset of patients who developed VTE. Table  IV shows data recorded for each of the nineteen patients who developed VTE. The highest VTE incidence occurred during the first fifteen days following surgery, with the last event documented at fifty-five days after surgery (Fig. 1 ).
Infections and Other Wound Complications
Infections and other wound complications were documented for eleven (3.3%) of the operations (Table II) . None of the patients with wound complications had VTEs. There were three hematomas (0.9% of the operations) requiring alteration in anticoagulation therapy or operative release, two (0.6%) major or deep infections requiring irrigation and debridement, two cases (0.6%) of culture-positive superficial cellulitis requiring 1507 16, 2015 antibiotic treatment, two cases (0.6%) of wound warmth and erythema (suspected to be cellulitis but without documented culture data) requiring antibiotic treatment, one case (0.3%) of wound breakdown requiring packing and dressing changes, and one case (0.3%) of septic shock in the setting of suspected wound infection with resultant death. There was no correlation between a specific anticoagulant and the rate of a wound complication (Table V) . In the analysis of anticoagulant use, we did not identify a significant relationship between the use of any of the anticoagulants studied and the development of DVT, PE, or VTE (p = 0.69, p = 0.27, and p = 0.32, respectively).
Statistical Analysis
There was a significant decrease in the risk of the development of PE in patients who did not receive radiation therapy (OR = 0.28 [95% CI = 0.7 to 0.94]; p = 0.026), but a relationship between the use of radiation therapy and DVT could not be shown (OR = 0.71 [95% CI = 0.18 to 3.00]; p = 0.75). We did find a slightly decreased risk, which approached significance, of the development of VTE overall in patients who did not receive radiation therapy (OR = 0.43 [95% CI = 0.15 to 1.14]; p = 0.064).
Multivariable Analysis
Multivariable logistic regression analysis was then performed to look at VTE risk overall as well as PE and DVT risk specifically. As demonstrated in the univariable analysis, we found a significantly increased risk of the development of VTE overall in patients with lung-cancer histology (OR = 7.49 [95% CI =1.56 to 36 .07]; p = 0.012). The relationship between the absence of radiation therapy and the development of VTE approached significance (OR = 0.35 [95% CI = 0.10 to 1.20]; p = 0.096) (Table VI) .
With respect to the development of PE, we found a significantly increased risk in patients with lung-cancer histology (OR = 24. (Table VII) . With respect to DVT risk specifically (Table VIII) , we found no significant correlation between the risk of the development of DVT and any of the variables tested. Discussion P atients undergoing intramedullary nailing for skeletal metastatic disease are at high risk for the development of a thromboembolic event postoperatively. Our goal was to investigate the risk of VTE and the rate of wound complications in this population, and our study included a series of 287 consecutive patients treated with intramedullary nailing for 336 metastatic long-bone lesions. We performed both univariable analysis and, using all variables presumed to be relevant to VTE, multivariable analysis. 16, 2015 Demographic data demonstrated a median age of 60.5 years (Table I) . As expected, the femur was the most common site, followed by the humerus, and then the tibia. Although we suspected there may be a difference in risk of VTE on the basis of location-because lesions in the lower extremity have greater impact on patient mobility-this was not our finding. The fact that the location of the lesion did not confer additional risk for VTE, even in the case of pathologic fracture, may suggest that the effect of having skeletal metastatic disease alone outweighs the VTE risk imparted by immobility due to the presence of, or fracture through, a lesion.
The overall rate of thromboembolic events in this study population was 7.1% (twenty-four of 336), with eleven of the twenty-four being DVT, and thirteen of the twenty-four, PE. Interestingly, the development of VTE was not significantly related to the type of anticoagulant used. The study population was treated with a variety of postoperative anticoagulants, including low-molecular-weight heparin, Coumadin (warfarin), aspirin, fondaparinux, and heparin, or in some cases, no chemical anticoagulation at all. Given the relatively low numbers of thromboembolic events seen in this study, it is possible that the study was underpowered to detect a difference among these agents. However, given the high number of risk factors in this patient population, it is also possible that none of the current regimens of postoperative thromboembolic prophylaxis substantially decrease the risk of DVTor PE when compared with no anticoagulation. A study designed to specifically answer this question is required.
Regarding the timing of VTE in this population after surgery, we considered the ninety-day period after the operation to be the "postoperative period" in which the incidence of VTE was investigated. A New England Journal of Medicine study on abdominal cancer surgery, in which patients were randomized to placebo versus enoxaparin as a thromboembolic prophylactic agent, demonstrated a significant difference with respect to the development of thromboembolic events for three months 29 . The landmark "Million Women Study" found significantly increased risk of postoperative thromboembolism for twelve weeks in 1.3 million women with breast cancer undergoing surgical procedures for the cancer 30 . On the basis of this literature, we elected to include any VTE within a ninety-day period postoperatively as a "postoperative" event. As demonstrated in Figure 1 , although half of the documented VTE events occurred within about two weeks after surgery, there were continued events noted as far as fifty-five days after surgery. This suggests that if there were an anticoagulant that could adequately prevent VTE, but it was used only for two weeks, it would have prevented only about half of the noted VTE events in this study. This potentially supports a longer duration of treatment, which is consistent with the findings of the Million Women Study 30 . Considering the high risk associated with this population, we believe this is likely warranted. Further investigation is needed to elucidate the precise ideal duration of anticoagulation postoperatively in this population.
Although we did not find a significant relationship between sex and VTE, multivariable logistic regression analysis showed a borderline significant relationship (OR = 0.26 [95% CI = 0.07 to 1.07]; p = 0.062) between male sex and decreased risk of VTE, and we observed that a high percentage (78.9%) of patients who developed VTE were female. There may be a relationship between female sex and development of VTE that we could not demonstrate because the study was underpowered. In studies of risk factors for VTE in the general (i.e., noncancer) population, females in childbearing years have a higher risk of DVT than do males, but this risk reverses after the age of fifty, when males are found to have a higher risk 31 . It is suspected that hormonal factors present in females during childbearing years, or other factors such as oral contraceptive use in the general population, may contribute to this increased risk. In the cancer population, alteration of the hormonal milieu could theoretically contribute to a sex-related risk. Although our study was not designed to investigate these specific concepts, the observation is interesting to note.
As expected, various primary histologies were seen in our patient population. When compared with other histologies, there was a significantly higher risk of developing VTE in patients with a primary tumor of the lung, which was demonstrated in both univariable and multivariable analyses. This is similar to other studies of thromboembolic events in patients with primary cancers that have shown that lung cancer is the most common primary cancer diagnosis at the time of a VTE event 28, 32 . Possible reasons for this increased risk for lung cancer patients include a hypercoagulable state, substantial chemotherapy usage, circulating procoagulants, or other undescribed factors unique to lung cancer patients.
Adjuvant therapies used included both chemotherapy and radiation therapy. Although a significant decrease in VTE risk in patients who were not receiving radiation therapy could not be demonstrated, this relationship did approach significance in both univariable (OR = 0.43 [95% CI = 0.15 to 1.14]; p = 0.064) and multivariable analysis (OR = 0.35 [95% CI = 0.10 to 1.20]; p = 0.096). Patients who did not receive radiation therapy were found to be at decreased risk for PE in both univariable and multivariable analyses. A significant relationship between the use of radiation therapy and increased risk of DVT could not be shown in this study. This is likely due to the study being underpowered to detect these individual differences. Overall, these findings are in agreement with those of other studies, which suggest that radiation increases the risk of VTE 33 . The overall rate of wound complications was 3.3%. Although we did not find a relationship between the anticoagulant used and the development of wound complications, this is a relatively rare complication, and the numbers for each type of anticoagulant were low, so the study was very likely underpowered to detect a difference. In arthroplasty procedures, there is a well-documented increase in wound complications with increasing levels of anticoagulation 34 . As the incisions and dissection required for intramedullary nailing are much more limited than arthroplasty incisions, it is possible that the wound complication risk is less dependent on the anticoagulant used than it is in arthroplasty. In this study, only two patients (0.6% of the operations) required a repeat operation for deep wound infection, and only one of the patients required removal of the hardware. This again is considerably different from findings for the arthroplasty population, in which a higher rate of implant removal is seen secondary to wound complications [35] [36] [37] . The use of intramedullary nailing in the setting of trauma also has been associated with a low risk of wound complication or infection requiring removal of the implant 38 . These results suggest, given the low risks of infection, wound complications, and hardware removal, that at least from a wound-risk standpoint, more aggressive anticoagulation could potentially be tolerated. Further study with a much larger population would be needed to determine if wound complication risk varies by anticoagulant.
Our study had several limitations. This was a retrospective study, and the limitations of this type of study design apply. Although it involved, to our knowledge, the largest series of its kind, the number of patients and thromboembolic events was still relatively small, which introduces the possibility that the study was underpowered to detect small differences and rare complications. Only symptomatic VTE was included in the study, which likely represents an underestimation of the true VTE occurrence in this population. This is a highly complex patient population, with multiple comorbidities and other disease-related factors, which could have had a confounding effect on our study.
On the basis of our results, several considerations are warranted. First, it is likely that the optimal postoperative anticoagulation protocol for this population has yet to be determined, and a clinical trial would be useful in elucidating the optimal postoperative management. Second, because the rate of wound complications seen in this study and in other studies is very low, and implant retention is the norm in the setting of wound complication, more aggressive anticoagulation may not introduce a notable patient morbidity specifically from the standpoint of wound risk. Third, anticoagulation protocols may need to be adjusted according to the patient's particular primary disease. Likewise, the optimal anticoagulation protocol should take into account the use of postoperative radiation therapy. The risk of thromboembolic events in the population of patients undergoing intramedullary nailing for metastatic disease involving long bones is clearly high, and the results presented here suggest that the current approach to anticoagulation therapy in this patient population is likely to be inadequate. n
